DKA/HHS.

Slides:



Advertisements
Similar presentations
Diabetic Ketoacidosis in Children
Advertisements

Management. Laboratories Glucose electrolytes BUN Creatinine CBC ABG Urinalysis ECG.
Management of Diabetic Ketoacidosis in the PICU
Block 9 Board Review Endocrine/Rheum 14Feb14 Chauncey D. Tarrant, M.D. Chief of Residents
Diagnosis and Management of Hyperglycemic Crises
Diabetic Ketoacidosis and Hyperglycemia
Electrolyte and Metabolic Disturbances AHMED GHALI MD.
Diabetic Ketoacidosis
Canadian Diabetes Association Clinical Practice Guidelines Hyperglycemic Emergencies in Adults Chapter 15 Jeannette Goguen, Jeremy Gilbert.
Diabetic Ketoacidosis Michele Ritter, M.D. Argy Resident – February, 2007.
Presentation title SUB TITLE HERE A Nimalasuriya MD Maria Ureña RN, MHA Diabetic Ketoacidosis Management.
Diabetic keto-acidosis (DKA) DKA or Hyperglycemia coma is defined when blood sugar mg/dl Is primarily seen in I.D.DM - can be seen in NIDDM. DKA.
Hyperglycaemia Diabetes Outreach (August 2011). 2 Hyperglycaemia Learning objectives >Can state what hyperglycaemia is >Is aware of the short term and.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Diabetes Claire Nowlan Nov 28, Comparison of type 1 and 2 diabetes Type 1 10% of diabetics Age of onset – young Severe Requires insulin Normal build.
Endocrine Disorders Dr. Naiema Gaber
بسم الله الرحمٰن الرحيم
Clinical Case 3. A 14 year old girl was brought to her GP’s office, complaining of: – weight loss, – dry mouth, – lethargy, – easy fatigability – and.
Endocrine Emergencies Prof. Mohamad S. Al-Hadramy Professor of Medicine/Consultant Prof. Mohamad S. Al-Hadramy Professor of Medicine/Consultant.
Copyright 2008 Society of Critical Care Medicine Management of Life- Threatening Electrolyte and Metabolic Disturbances.
Management of Diabetic Ketoacidosis
Diabetes Mellitus Type 1
Diabetic Ketoacidosis Management
Diabetic Ketoacidosis Management
Case 6 A 54 year old obese person come in emergency with altered consciousness level and increase respiratory rate (tachypnia) for last 4 hours. He is.
Diabetic Ketoacidosis DKA)
Management of diabetic ketoacidosis and hypoglycemia Prof. Hanan Hagar.
Assistant Professor of Clinical Pharmacy
Endocrine 3 Part 2.
Module 3 Initial Recognition, Triaging, and Management of Hyperglycemia Diabetes Special Interest Group Georgia Hospital Association.
Acute Complications of DM Dr. ghanei Endocrinologist.
ACUTE COMPLICATIONS. 18 years old diabetic patient was found to be in coma What questions need to be asked ? Differentiating hypo from hyperglycemia ?
Adult Medical-Surgical Nursing Endocrine Module: Acute Complications of Diabetes Mellitus.
Diabetic Emergencies Abdullah ALSAKKA EM. Consultant
DIABETIC KETOACIDOSIS Meera Ladwa. Defined as  Blood glucose > 11mmol/L  Blood ketones > 3mmol/L (or urine ketones 2+ and above)  pH < 7.3 (or venous.
DIABETIC KETOACIDOSIS By, Dr. ASWIN ASOK CHERIYAN Chair Person – Dr. JAYAMOHAN A.S.
Management of diabetic ketoacidosis Prof. M.Alhummayyd.
Management of diabetic ketoacidosis (DKA) Prof. M.Alhummayyd.
Acute Diabetes Case B By: Abdullah Osman Christine Tanzil Ayse Togac.
Hyperglycemic Emergencies Dr. Miada Mahmoud Rady Ems/474 Endocrinal Emergencies Lecture 3.
Diabetic Ketoacidosis.  An anion gap acidosis due to severe insulin deficiency and excess of counterregulatory hormones.
Diabetic Ketoacidosis Management
H YPERGLYCEMIC E MERGENCIES IN A DULTS Rohit Gandhi PGY-2 Family Medicine September 2015.
DIABETES CASE PRESENTATIONS
Diabetic Ketoacidosis DKA PHCL 442 Lab Discussion 6 Raniah Al-Jaizani M.Sc.
Endocrine System KNH 411. Diabetes Mellitus 7% of population; 1/3 undiagnosed $132 billion in health care Sixth leading cause of death Complications of.
D IABETIC KETOACIDOSIS (DKA) Hannah Allegretto University of Pittsburgh School of Pharmacy PharmD Candidate 2013.
DIABETIC KETOACIDOSIS Emergency pediatric – PICU division H. Adam Malik Hospital – Medical School University of Sumatera Utara 1.
DKA - Some objective and evidence based aspects that may change our standard management. Sources: 1 ADA Clinical Practice Recommendations Joint.
Endocrine Clinical Assessment and Diagnostic Procedures DKA
Management of Diabetic Ketoacidosis
Diabetic Ketoacidosis Dr. Bilal Hammad. M.D Endocrinologist Diabetologist.
Management of Adult Diabetic Ketoacidosis Adapted from the WHO IMAI District Clinician Manual Vol. 1 Dr. Linda Hawker, June 2014.
Pediatric endocrine fellow
Annelize Mostert February 2017 Ngwelezana Hospital
DKA TREATMENT GUIDELINES.
ACUTE COMPLICATIONS.
ACUTE COMPLICATIONS.
Management of diabetic ketoacidosis
Endocrine System KNH 411.
Endocrine Emergencies & Management
Endocrine System KNH 411.
Diabetes.
Endocrine System KNH 411.
Paul Szczybor PA-C DFAAPA Lifebridge Critical Care
2018 Clinical Practice Guidelines Hyperglycemic Emergencies in Adults
Endocrine System KNH 411.
Endocrine System KNH 411.
Endocrine System KNH 411.
Endocrine Emergencies
Presentation transcript:

DKA/HHS

DKA/HHS Incidence Physiology Diagnosis Predisposing Factors Treatment

Diabetic Ketoacidosis 115,000 hospitalizations in U.S - 2003 10-30% of admissions with primary diagnosis of Diabetes Mortality fallen 22% over the past 20 years

Hyperglycemic Hyperosmolar Syndrome Lower incidence compared to DKA 1% of DM related admissions Much high mortality rate ~40% compared to <5% for DKA No significant improvement in recent past

Diagnosis Table with diagnostic parameters

DKA Triad Fig. #2.

Pathophysiology Insulin Deficiency Decreased Glucose utilization Increased Lipolysis Increased Ketoacids Increased Counterregulatory Hormones Osmotic Diuresis Dehydration Electrolyte Loss Potassium

Pathophysiology

DKA vs. HHS

Ketosis Prone T2DM Mostly minorities Presents with DKA African Americans and Hispanics Presents with DKA Require insulin treatment initially Can usually be transitioned quickly to Oral hypoglycemics as outpatient Due to Glucose toxicity or lipotoxicity to the Beta-Cells

Presentation Dehydration Weight loss Weakness Abdominal Pain polyuria, polydipsia Weight loss Weakness Abdominal Pain Correlates with severity of acidosis May be confused with Acute Abdomen

Presentation Mental Status changes Related to osmolality more than hyperglycemia or acidosis More common in HHS Signs & Symptoms related to underlying cause Infection, CV disease etc…

Which statement is incorrect Diabetic patients may have silent cardiac ischemia precipitating DKA even without chest pain. Infection is the most common precipitating factor for DKA. Cocaine and other illicit drugs are a common factor in DKA. Prescription drugs only rarely are a precipitating cause of DKA.

Predisposing Factors Acute Illness Infection CVA/MI Acute Pancreatitis Venous Thromboembolism Acute Abdomen Renal Failure Heat Stroke Burns Subdural Hematoma Thyrotoxicosis Cushing’s Syndrome Find good table of factors

Predisposing Factors Drugs Previously undiagnosed diabetes Pregnancy Glucocorticoids Beta-Blockers Anti-Psychotics Thiazide Diuretics Niacin TPN Previously undiagnosed diabetes Pregnancy Corticosteroids for lung maturity Terbutiline to prevent pre-term labor

Evaluation Metabolic Panel Arterial Blood Gas CBC, Cultures Glucose, Na, K, CL, BUN, SCr Anion Gap, Calculate Osm Arterial Blood Gas CBC, Cultures ECG, required in all older patients Remainder driven by Hx & Px

Anion Gap (Na+) - [(Cl-) + (HCO3)] = 12 +/- 2 Increased ketoacids are the cause for acidosis in DKA

Calculated Osmolality 2(Na+) + Glu/18 = 285-295 >320 usually associated with Mental status change

Treatment Fluids Potassium Insulin Acidosis Monitoring and Transition

Fluids Most Important Initial Treatment Give Normal Saline, 1-1.5 liter in first hr Can Switch to .45% Saline when patient is Volume replaced and has normal Na+ Add 5% Dextrose when Glucose is <250mg/dl.

Which of these therapies for DKA may worsen hypokalemia? And Why? IV Fluid Hydration Insulin Bicarbonate All of the above

Potassium K+ is total body deficient May be normal to high at presentation Acidosis, Insulin deficiency May start supplementation when K+ is <5.0 K+ 4-5meq/L start with 20mEq/L of fluids K+ 3.3-4mEq/L - 40mEq/L of fluids

Potassium K+ < 3.3mEq/L - Hold Insulin Insulin will drive K+ into cells acutely High risk of Hypokalemic arrhythmia Give 10-20mEq/L per hour until >3.3 Continue to add 40mEq/L to fluids after starting insulin

Insulin Fluids and Potassium first! Start with 0.1unit/Kg IV bolus Insulin in pt that is hypovolemic will produce hypotension secondary to fluid shifts Insulin drives K+ into the cells causing hypokalemia Start with 0.1unit/Kg IV bolus

Insulin Start Insulin drip Mild cases may be treated with SC insulin 0.1unit/Kg/Hr as continuous infusion Goal is to lower Glucose 50-70mg/hr Do Not Forget: Add 5% Dextrose when glucose <250mg/dl Goal to keep Glucose 150-200 with continued insulin infusion Why?

What do you follow to prove the ketoacidosis has resolved? pH on ABG Plasma Glucose Anion Gap Serum Ketones Serum Bicarbonate

Close the Gap Insulin necessary to utilize glucose and decrease ketoacids Recommend continuing insulin infusion until Anion Gap and acidosis resolved Important to transition to SC insulin and make sure patient is eating before stopping the insulin infusion

Acidosis Decrease Ketoacids Bicarbonate Fluids increase renal clearance Insulin decreases production Bicarbonate Consider bicarb only if pH<7.0 - Life threatening Otherwise no indication

Phosphate Not an immediate concern Consider treatment if Phos <1.0mg/dl. Change KCl replacement to K-Phos This may help avoid hyperchorlemic acidosis sometimes associated with aggressive NS fluids

DKA vs. HHS Differences in treatment: Fluid deficit is larger in HHS Add 5% Dextrose at 300mg/dl in HHS No acidosis or AG to follow HHS resolved when Glucose is <300mg/dl, Osmolality <320mEq/L and mental status is clear

Transition to sc Insulin and Ward!

Transition Continue Insulin infusion until resolution of ketoacidosis Start SC insulin at least 1-2 hrs before stopping the infusion Think Ahead: if planning/hoping to stop infusion - consider starting low dose SC insulin that morning or long acting SC insulin the night before

Transition Make sure the patient is eating before stopping the infusion Transition is where I see most mistakes made causing either return to ICU or prolonged stay

Insulin Dosing Based on underlying cause If Non-compliance - return to previous dosing that showed good control Underlying medical disease may cause increased insulin requirements Several protocols available if patient is newly diagnosed Diabetic Endocrine team is happy to help!

Starting Insulin Weight based insulin regimen 0.4 – 0.8units/Kg/day How much depends on insulin resistance Obesity Fam hx of type II DM Concomitant illness 40-50% of total as basal and the rest distributed as short acting insulin with meals

Questions?